On March 25, 2026, Silexion Therapeutics Corp announced the removal of Ilan Levin from its Board of Directors. This decision was made unanimously by the remaining board members in accordance with Article 28.7 of the company's Amended and Restated Articles of Association. The removal is effective immediately, indicating a significant change in the company's leadership structure. Such changes can often lead to shifts in company strategy and governance, which may impact investor confidence and stock performance. The company has not provided further details regarding the reasons behind this decision or any potential implications for its operations or strategic direction. Investors and stakeholders will be closely monitoring the situation to assess how this leadership change might affect the company's future performance and governance practices.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.